More than 26% of total health care expenditures in 2010 were on pharmaceuticals. Compared to other OECD countries thus Slovakia had the third highest share of expenditures on pharmaceuticals, right after Hungary and Mexico. Slovakia got well above the average of all OECD countries, which stands at 16.6%. This was alleged in the OECD Health Data 2012 report published on the website of the organization, which provides information from 2010.